Fresia Pareja Selected Research

Intraductal Papilloma

1/2020	Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity.
1/2016	Breast intraductal papillomas without atypia in radiologic-pathologic concordant core-needle biopsies: Rate of upgrade to carcinoma at excision.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fresia Pareja Research Topics

Disease

30	Neoplasms (Cancer) 01/2022 - 01/2013
16	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2013
6	Carcinoma (Carcinomatosis) 01/2021 - 01/2016
3	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2021 - 01/2019
3	Triple Negative Breast Neoplasms 10/2017 - 01/2013
2	Adenomyoepithelioma 01/2021 - 01/2018
2	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2021 - 01/2016
2	Intraductal Papilloma 01/2020 - 01/2016
2	Papillary Carcinoma 01/2020 - 08/2018
2	Acinar Cell Carcinoma 12/2019 - 01/2017
2	Neoplasm Metastasis (Metastasis) 08/2017 - 01/2015
1	Fibroadenoma 02/2022
1	Carcinogenesis 01/2022
1	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2022
1	Residual Neoplasm 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 01/2022
1	Small Cell Carcinoma 10/2021
1	Rhabdoid Tumor (Rhabdoid Tumors) 10/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Adenoid Cystic Carcinoma (Cylindroma) 01/2021
1	Diarrhea 01/2021
1	Hyperglycemia 01/2021
1	Hypokalemia 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Lobular Carcinoma 01/2021
1	Mucositis 01/2021
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2020
1	Thyroid Neoplasms (Thyroid Cancer) 08/2018
1	Papillary Thyroid Cancer 08/2018
1	Endometrioid Carcinoma 09/2017
1	Fibrocystic Breast Disease (Chronic Cystic Mastitis) 01/2017
1	Disease Progression 01/2016
1	Sarcoma (Soft Tissue Sarcoma) 03/2015
1	Adenocarcinoma 03/2015
1	Adenocarcinoma of Lung 03/2015
1	Glioblastoma (Glioblastoma Multiforme) 07/2014

Drug/Important Bio-Agent (IBA)

10	Estrogen ReceptorsIBA 01/2021 - 01/2016
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2015
6	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 09/2017
5	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2019
3	Trastuzumab (Herceptin)FDA Link 01/2021 - 01/2017
3	MucinsIBA 01/2021 - 01/2019
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2017 - 01/2013
3	ErbB Receptors (EGF Receptor)IBA 03/2015 - 01/2013
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2022
2	Adenosine Triphosphatases (ATPase)IBA 01/2022 - 10/2021
2	Hormones (Hormone)IBA 01/2022 - 10/2018
2	AntibodiesIBA 01/2020 - 01/2013
2	Monoclonal AntibodiesIBA 01/2020 - 01/2013
2	human ERBB2 proteinIBA 01/2017 - 01/2013
1	Mediator ComplexIBA 02/2022
1	Telomerase (Telomerase Reverse Transcriptase)IBA 02/2022
1	Verteporfin (Visudyne)FDA Link 01/2022
1	Biological ProductsIBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	B7-H1 AntigenIBA 01/2022
1	ChromatinIBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 09/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2021
1	AlpelisibIBA 01/2021
1	EnzymesIBA 01/2021
1	Lipase (Acid Lipase)FDA Link 01/2021
1	elgemtumabIBA 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 01/2021
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2021
1	Keratins (Keratin)IBA 01/2020
1	VimentinIBA 01/2020
1	Mitogen-Activated Protein KinasesIBA 10/2018
1	bis(pyridinio)dichlorocuprate(II)IBA 08/2018
1	Codon (Codons)IBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	Lapatinib (GW572016)FDA Link 01/2018
1	MTOR InhibitorsIBA 07/2017
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2017
1	Tamoxifen FDA LinkGeneric 01/2017
1	Inosine Diphosphate (IDP)IBA 01/2016
1	Anaplastic Lymphoma KinaseIBA 03/2015
1	LipidsIBA 01/2015
1	synaptojaninIBA 01/2015
1	MicroRNAs (MicroRNA)IBA 01/2015
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2015
1	navitoclaxIBA 07/2014
1	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 07/2014
1	N- (oxo- 5,6- dihydrophenanthridin- 2- yl)- N,N- dimethylacetamide hydrochlorideIBA 01/2014
1	Estrogens (Estrogen)FDA Link 01/2013

Therapy/Procedure

11	Therapeutics 01/2022 - 01/2015
2	Drug Therapy (Chemotherapy) 01/2020 - 01/2018
1	Immunotherapy 01/2022
1	Hyperthermic Intraperitoneal Chemotherapy 01/2022
1	Radiotherapy 01/2020
1	Precision Medicine 10/2017
1	Adjuvant Chemotherapy 01/2017